Erdogan Vote Momentum Pushes Traders to Delay Bets on Lira Slide
Investors have come to terms with the prospect that President Recep Tayyip Erdogan’s unconventional stewardship of the economy
2023-05-17 18:58
Goldman Sachs Slashes Adani Group Stakes From Its ESG Funds
The investment arm of Goldman Sachs Group Inc. dramatically reduced its exposure to the Adani Group in its
2023-05-17 18:54
Elon Musk Says Tesla Will Try Advertising
Tesla Inc. Chief Executive Officer Elon Musk said the electric-car maker will dabble in advertisements, a major shift
2023-05-17 17:58
Swiss Government Wants to Enshrine Cash in the Constitution
The Swiss government wants to enshrine the availability of cash in the constitution and will let citizens decide
2023-05-17 17:56
Wall Street’s Dependence on London Clearing Worries EU Watchdog
Wall Street banks have made “no significant moves” away from London’s dominant clearing service since Brexit, raising concerns
2023-05-17 17:56
UK Cracks Down on Landlords in Private Rental Sector Reform
The UK government is preparing to lay out a series of extra protections for tenants in the biggest
2023-05-17 17:52
It’s the G-7 Versus China and Russia in the Struggle for Global Influence
The tussle for global influence is about to intensify, as China, Russia, the US and its allies step
2023-05-17 17:52
Sony to Buy Back Up to $1.5 Billion in Shares Over Next Year
Sony Group Corp. plans a buyback of up to 2.03% of its shares over the course of the
2023-05-17 16:51
Tencent’s Revenue Grows Most in Over a Year After China Reopens
Tencent Holdings Ltd. grew revenue at its fastest pace in more than a year, fueling hopes the world’s
2023-05-17 16:48
Theme Park Boss Urges Sunak to Reverse Tourism Tax
The new boss of Alton Towers-owner Merlin Entertainments Ltd. has urged the UK government to bring back a
2023-05-17 16:27
SAP Says It’s Open to Acquisitions After Qualtrics Sale
SAP SE, which recently agreed to divest its stake in Qualtrics International Inc., is open to making acquisitions
2023-05-17 16:26
Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data
European biotech firm Argenx SE is scheduled to release key drug trial data this summer. Deal-hungry Big Pharma
2023-05-17 16:20
You Might Like...
Restaurant Chain Cava Projects Profit Growth in First Update Since June IPO
Novo to Build $6 Billion Plant as Obesity Drug Demand Surges
Sternlicht’s Starwood Eyes Sale of More Than 2,000 Rental Homes
Yen Weakens Past 140 Per Dollar as Traders See Another Fed Hike
Bitcoin ETF Hype Threatens Another Sell-The-News Fizzle
Saudi Arabia’s Neom, DSV Form $10 Billion JV for Futuristic City
Rupee’s Plunging Volatility Leaves Investors Guessing RBI Moves
Collateralized Loan Obligations Deliver Worst Returns in Years
